Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Metabolism. 2013 Mar 14;62(8):1052–1056. doi: 10.1016/j.metabol.2013.02.002

Table 1.

Between-treatment differences in body composition and serum markers

Variable OLETF SED (n=7) LETO SED (n=6)
Body composition variables
Bodyweight (g) 693 ± 14 474 ± 19***
DXA bfat (%) 37.0 ± 1.6 14.9 ± 0.6***
Lean mass (g) 435 ± 8 407 ± 17
fat mass (g) 257 ± 15 72 ± 5***
Serum markers
Glucose (mg/dl) 290 ± 14 151 ± 5***
Insulin (mg/dl) 6.2 ± 0.6 2.8 ± 0.6**
HDL-c (mg/dl) 33 ± 2 26 ± 1*
LDL-c (mg/dl) 50 ± 7 61 ± 4
Triglycerides (mg/dl) 319 ± 47 40 ± 5***
Plasma adipokines
Leptin (ng/ml) 102 ± 11 13 ± 2***
IL-1β (pg/ml) 17 ± 13 ND
IL-6 (pg/ml) 825 ± 222 ND
IL-10 (pg/ml) 927 ± 332 34 ± 10*
IL-12p70 (pg/ml) 125 ± 66 12 ± 5
TNF-α (pg/ml) 8.9 ± 4.2 3.9 ± 1.9
MCP-1 (pg/ml) 49 ± 10 56 ± 28
RANTES (pg/ml) 938 ± 69 1218 ± 334

All data are presented as mean ± SE.

Abbreviations: DXA bfat = dual x-ray absorptiometry body fat percentage, ND = not detectable;

*

indicate a significant difference between groups (p < 0.05),

**

indicate a significant difference between groups (p < 0.01),

***

indicate a significant difference between groups (p < 0.001).